FoodNov 13, 2019
Whole Foods Market White Parkerhouse Rolls PLU 49557 NET WT recall — FDA F-0131-2020
Undeclared milk and eggs
Class IFDA: TerminatedWhole Foods Market
Monthly breakdown
2019 recalls by month
Select a month to review the recall records reported during that period.
December 2019321 records · 4 categoriesNovember 2019597 records · 4 categoriesOctober 2019525 records · 4 categoriesSeptember 2019268 records · 4 categoriesAugust 2019505 records · 4 categoriesJuly 2019680 records · 4 categoriesJune 2019445 records · 4 categoriesMay 2019396 records · 4 categoriesApril 2019242 records · 4 categoriesMarch 2019250 records · 4 categoriesFebruary 2019381 records · 4 categoriesJanuary 2019142 records · 4 categories
2019 recalls — page 35
Records are ordered by the best available source date.
FoodNov 13, 2019
Wawona Frozen Foods Season s Choice recall — FDA F-0437-2020
FDA sampling found Hepatitis A in frozen raspberries.
Class IFDA: TerminatedWawona Frozen Foods Inc.
FoodNov 13, 2019
Dollar General Sweet Smiles brand Select Dark Chocolate with Orange Peel Bar recall — FDA F-0136-2020
Possible undeclared milk allergen in product.
Class IIFDA: TerminatedDollar General Corporation
DrugNov 13, 2019
Basic Reset CBD Reset 2400, True Full Spectrum Natural (unflavored), 2400 mg CBD, 1 fl. oz. recall — FDA D-0194-2020
Marketed without an Approved NDA/ANDA
Class IIFDA: TerminatedBasic Reset Inc.
DrugNov 13, 2019
Basic Reset BIOGENYX True Full Spectrum CBD Oil Cinnamon, 1 fl. oz. (30 mL) bottle, 750 mg recall — FDA D-0197-2020
Marketed without an Approved NDA/ANDA
Class IIFDA: TerminatedBasic Reset Inc.
DrugNov 13, 2019
Dr. Reddy's Laboratories Ranitidine Tablets, USP 75 mg, a.) 30 count bottles recall — FDA D-0173-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
Dr. Reddy's Laboratories Ranitidine Tablets, USP 150 mg, a.) 24 count bottles recall — FDA D-0177-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
RANITIDINE HYDROCHLORIDE Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles recall — FDA D-0180-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
Dr. Reddy's Laboratories Ranitidine Tablets, USP 150 mg, a.) 24 count bottles recall — FDA D-0170-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
First Royal Care Co. LLC, dba Red Mountain S-MIC/B12(C)/CARNITINE 25/50/50/1/50MG/ML MDV INJ recall — FDA D-0274-2020
Lack of Assurance of Sterility
Class IIFDA: TerminatedFirst Royal Care Co. LLC, dba Red Mountain Compounding…
DrugNov 13, 2019
First Royal Care Co. LLC, dba Red Mountain S-TRIMIX various strengths to include:a) S-TRIMIX recall — FDA D-0297-2020
Lack of Assurance of Sterility
Class IIFDA: TerminatedFirst Royal Care Co. LLC, dba Red Mountain Compounding…
DrugNov 13, 2019
Basic Reset BIOGENYX True Full Spectrum CBD Oil Wintergreen, 1 fl. oz. (30 mL) bottle, 750 recall — FDA D-0195-2020
Marketed without an Approved NDA/ANDA
Class IIFDA: TerminatedBasic Reset Inc.
DrugNov 13, 2019
Basic Reset Nuovi Firming Masque, Renew and Reset, 2 fl. oz. 59 mL bottle, Made in USA recall — FDA D-0190-2020
Marketed without an Approved NDA/ANDA
Class IIFDA: TerminatedBasic Reset Inc.
DrugNov 13, 2019
RANITIDINE HYDROCHLORIDE Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles recall — FDA D-0168-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
Dr. Reddy's Laboratories Ranitidine Tablets, USP 150 mg, a.) 95 count bottles recall — FDA D-0176-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
Basic Reset BIOGENYX True Full Spectrum CBD Oil Natural Flavor, 1 fl. oz. (30 mL) bottle recall — FDA D-0196-2020
Marketed without an Approved NDA/ANDA
Class IIFDA: TerminatedBasic Reset Inc.
DrugNov 13, 2019
Dr. Reddy's Laboratories Ranitidine Tablets, USP 150 mg, 190 count bottles (2x95) Tray recall — FDA D-0169-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
Basic Reset CBD Reset 750 True Full Spectrum Wintergreen, 750 mg CBD, 1 fl. oz. (30 mL) recall — FDA D-0191-2020
Marketed without an Approved NDA/ANDA
Class IIFDA: TerminatedBasic Reset Inc.
DrugNov 13, 2019
Dr. Reddy's Laboratories Ranitidine Tablets, USP 150 mg, a.) 24 count bottles recall — FDA D-0172-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
Dr. Reddy's Laboratories Ranitidine Tablets, USP 75 mg, a.) 30- count bottles recall — FDA D-0183-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
Lupin Pharmaceuticals Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle recall — FDA D-0304-2020
Presence of Foreign substance: identified as a dead ant.
Class IIIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugNov 13, 2019
Cefdinir for Oral Suspension USP, 125 mg/5mL recall — FDA D-0306-2020
Presence of Foreign substance: identified as a dead ant.
Class IIIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugNov 13, 2019
Dr. Reddy's Laboratories Ranitidine Tablets, USP 150 mg, a.) 24 count bottles recall — FDA D-0184-2020
CGMP Deviations: Presence of NDMA impurity detected in product.
Class IIFDA: CompletedDr. Reddy's Laboratories, Inc.
DrugNov 13, 2019
Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle recall — FDA D-0305-2020
Presence of Foreign substance: identified as a dead ant.
Class IIIFDA: TerminatedLupin Pharmaceuticals Inc.
About the 2019 recall archive
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.